Quarterly Result14 Feb 2026, 04:42 pm
Norris Medicines Ltd. Approves Un-Audited Financial Results for Q3 & Year Ended 31st Dec, 2025
AI Summary
Norris Medicines Ltd. announced the approval of their un-audited financial results for the quarter and nine months ended 31st December, 2025 during a Board Meeting held on 14th February, 2026. The meeting was conducted from 3:15 PM to 3:45 PM IST. The company will publish the financial results in newspapers as per Regulation 47 of the Listing Regulations.
Key Highlights
- Norris Medicines Ltd. approved un-audited financial results for Q3 and year ended 31st December, 2025.
- The approval was given during a Board Meeting on 14th February, 2026.
- The meeting was held from 3:15 PM to 3:45 PM IST.
- The company will publish the financial results in newspapers as required by Regulation 47 of the Listing Regulations.
- The financial results were prepared in accordance with Indian Accounting Standards and other accounting principles generally accepted in India.
Price Impact
More from NORRIS